DK571484A - SUBSTITUTED ETHYLENDIAMINE DERIVATIVES AND THEIR PREPARATION AND USE - Google Patents
SUBSTITUTED ETHYLENDIAMINE DERIVATIVES AND THEIR PREPARATION AND USE Download PDFInfo
- Publication number
- DK571484A DK571484A DK571484A DK571484A DK571484A DK 571484 A DK571484 A DK 571484A DK 571484 A DK571484 A DK 571484A DK 571484 A DK571484 A DK 571484A DK 571484 A DK571484 A DK 571484A
- Authority
- DK
- Denmark
- Prior art keywords
- ethylendiamine
- derivatives
- substituted
- preparation
- substituted ethylendiamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH643683 | 1983-12-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK571484D0 DK571484D0 (en) | 1984-11-30 |
DK571484A true DK571484A (en) | 1985-06-02 |
Family
ID=4309613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK571484A DK571484A (en) | 1983-12-01 | 1984-11-30 | SUBSTITUTED ETHYLENDIAMINE DERIVATIVES AND THEIR PREPARATION AND USE |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0144290A3 (en) |
JP (1) | JPS60136595A (en) |
AU (1) | AU3609484A (en) |
DK (1) | DK571484A (en) |
ES (1) | ES8701142A1 (en) |
GR (1) | GR81124B (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI88400C (en) * | 1984-08-06 | 1993-05-10 | Upjohn Co | FRAMEWORK FOR THE FRAME STATION INHIBITION OF PEPTIDER |
JPH05501879A (en) * | 1989-10-27 | 1993-04-08 | ジ・アップジョン・カンパニー | Methods of treating HIV and other retroviruses and compounds useful therein |
FR2711990B1 (en) * | 1993-11-05 | 1995-12-08 | Exsymol Sa | Pseudodipeptide product having an imidazole group, and therapeutic, cosmetological and agrifood applications. |
WO1996004244A1 (en) * | 1994-08-05 | 1996-02-15 | Warwick International Group Limited | Bleach activators |
JP4484897B2 (en) * | 1995-12-08 | 2010-06-16 | 生化学工業株式会社 | Method for producing amino alcohol derivative |
GB9727123D0 (en) * | 1997-12-22 | 1998-02-25 | Int Centre Genetic Eng & Bio | Synthesis of diamines |
AU6075400A (en) * | 1999-07-06 | 2001-01-22 | Vertex Pharmaceuticals Incorporated | N-substituted glycine derivatives |
WO2005113582A1 (en) * | 2004-05-22 | 2005-12-01 | Boehringer Ingelheim International Gmbh | Substituted ethane-1,2-diamines for the treatment of alzheimer's disease |
JP2008519840A (en) | 2004-11-10 | 2008-06-12 | ジェンザイム・コーポレイション | How to treat diabetes |
JP5042040B2 (en) * | 2005-01-26 | 2012-10-03 | アラーガン、インコーポレイテッド | 1-Aryl-1-hydroxy-2,3-diamino-propylamine, 1-heteroaryl-1-hydroxy-2,3-diamino-propylamine and related compounds having analgesic and / or immunostimulatory activity |
ES2546181T3 (en) | 2006-05-09 | 2015-09-21 | Genzyme Corporation | Methods of treating fatty liver disease by inhibiting the synthesis of glycosphingolipids |
EP2167485B1 (en) * | 2007-05-31 | 2015-09-30 | Genzyme Corporation | 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
MX2010003603A (en) | 2007-10-05 | 2010-06-02 | Genzyme Corp | Method of treating polycystic kidney diseases with ceramide derivatives. |
CA2731685A1 (en) | 2008-07-28 | 2010-02-04 | Genzyme Corporation | Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease |
MX2011003517A (en) | 2008-10-03 | 2011-05-25 | Genzyme Corp | 2-acylaminopropoanol-type glucosylceramide synthase inhibitors. |
JP2020532562A (en) * | 2017-09-05 | 2020-11-12 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | Compounds for reducing the viscosity of biologics |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4198398A (en) * | 1977-07-12 | 1980-04-15 | Derek Hudson | Enkephalin analogues |
US4145337A (en) * | 1977-10-11 | 1979-03-20 | Hoffmann-La Roche Inc. | Aminoethylglycine containing polypeptides |
GB2058077B (en) * | 1979-06-08 | 1983-03-09 | Szelke M | Enkephalin analogues |
NO812612L (en) * | 1980-08-06 | 1982-02-08 | Ferring Pharma Ltd | ENZYME inhibitor. |
CA1245217A (en) * | 1981-12-10 | 1988-11-22 | Joshua S. Boger | Renin inhibitory peptides having phe su13 xx deletion |
EP0316965A3 (en) * | 1983-02-07 | 1989-08-09 | Aktiebolaget Hässle | Enzyme inhibitors |
US4661473A (en) * | 1984-03-27 | 1987-04-28 | Merck & Co., Inc. | Renin inhibitors containing peptide isosteres |
-
1984
- 1984-11-26 EP EP84810575A patent/EP0144290A3/en not_active Withdrawn
- 1984-11-30 GR GR81124A patent/GR81124B/en unknown
- 1984-11-30 DK DK571484A patent/DK571484A/en not_active Application Discontinuation
- 1984-11-30 AU AU36094/84A patent/AU3609484A/en not_active Abandoned
- 1984-11-30 ES ES538172A patent/ES8701142A1/en not_active Expired
- 1984-12-01 JP JP59252849A patent/JPS60136595A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
ES8701142A1 (en) | 1986-11-16 |
AU3609484A (en) | 1985-06-06 |
EP0144290A2 (en) | 1985-06-12 |
ES538172A0 (en) | 1986-11-16 |
JPS60136595A (en) | 1985-07-20 |
EP0144290A3 (en) | 1987-05-27 |
GR81124B (en) | 1985-03-26 |
DK571484D0 (en) | 1984-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK554784A (en) | SUBSTITUTED 5-AMINO-4-HYDROXYVALE RELEASE DERIVATIVES AND THEIR PREPARATION AND USE | |
DK559985A (en) | 13BETA-MILBEMYCINE DERIVATIVES AND THEIR PREPARATION AND USE | |
DK211582A (en) | ARYLPHENYLETHER DERIVATIVES AND THEIR PREPARATION AND USE | |
DK289886A (en) | SUBSTITUTED 3-PHENYL-4-CYANOPYRROL DERIVATIVES AND THEIR PREPARATION AND USE | |
DK410384D0 (en) | N- (2-NITROPHENYL) -4-AMINOPYRIMIDINE DERIVATIVES AND THEIR PREPARATION AND USE | |
DK41484A (en) | BETA-PHENETHANOLAMINES AND THEIR USE | |
DK317588A (en) | 2-ANILINO-PYRIMIDINE DERIVATIVES AND THEIR PREPARATION AND USE | |
DK571484D0 (en) | SUBSTITUTED ETHYLENDIAMINE DERIVATIVES AND THEIR PREPARATION AND USE | |
DK578185A (en) | 13BETA-MILBEMYCINE DERIVATIVES AND THEIR PREPARATION AND USE | |
DK614084D0 (en) | MILBEMYCIM DERIVATIVES AND THEIR PREPARATION AND USE | |
DK35884D0 (en) | LACTAMPEPTIDES AND THEIR PREPARATION AND USE | |
DK614384D0 (en) | SUBSTITUTED IMIDAZOLES AND THEIR PREPARATION AND USE | |
DK294684D0 (en) | N-ALKYLERED 3-PHENYL-4-CYANOPYRROL DERIVATIVES AND THEIR PREPARATION AND USE | |
DK45188A (en) | SUBSTITUTED AMINDER DERIVATIVES AND THEIR USE | |
DK297082A (en) | SUBSTITUTED 1-AZOLYL-2-HYDROXY ALKANDER DERIVATIVES AND THEIR PREPARATION AND USE | |
DK558484D0 (en) | MILBEMYCINE DERIVATIVES AND THEIR PREPARATION AND USE | |
DK537785A (en) | FLAVOLIGNAN DERIVATIVES AND THEIR PREPARATION AND USE | |
DK297182A (en) | SUBSTITUTED 2-HYDROXY-3-AZOLYL PROPANDER DERIVATIVES AND THEIR PREPARATION AND USE | |
DK189584D0 (en) | (5ALFA) -20-SPIROX-1-EN-3-ONER AND THEIR PREPARATION AND USE | |
DK419084A (en) | 2-AMINOMETHYL-2-PENEM COMPOUNDS AND THEIR PREPARATION AND USE | |
DK393285A (en) | SUBSTITUTED CARBONYLPHENYLSULPHONYLGUANIDINES AND THEIR PREPARATION AND USE | |
DK236585A (en) | ACYLED HEXOSIDE DERIVATIVES AND THEIR PREPARATION AND USE | |
DK35984D0 (en) | LACTAMPEPTIDES AND THEIR PREPARATION AND USE | |
DK422685D0 (en) | BENZAZOLD DERIVATIVES AND THEIR PREPARATION AND USE | |
DK153285D0 (en) | BENZODIOXOLD DERIVATIVES AND THEIR PREPARATION AND USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |